{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:28Z","timestamp":1793500528868,"version":"4.5.0"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6896","type":"journal-article","created":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T22:10:42Z","timestamp":1476483042000},"page":"3053-3058","source":"Crossref","is-referenced-by-count":11,"title":["Severe Disseminated &lt;i&gt;Mycobacterium avium&lt;\/i&gt; Infection in a Patient with a Positive Serum Autoantibody to Interferon-\u03b3"],"prefix":"10.2169","volume":"55","author":[{"given":"Hiroshi","family":"Ikeda","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ohta-Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiwamu","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Infection Control Unit, Ohta-Nishinouchi Hospital, Japan"},{"name":"Department of Infection Control, Fukushima Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Ikenori","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ohta-Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ohta-Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nagamine","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ohta-Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ohta-Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Sakagami","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Disease, Niigata University Graduate School of Medical and Dental Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Microbiological Laboratory Unit, Ohta-Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Usui","sequence":"additional","affiliation":[{"name":"Infection Control Unit, Ohta-Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kanemitsu","sequence":"additional","affiliation":[{"name":"Department of Infection Control, Fukushima Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Infection Control Unit, Ohta-Nishinouchi Hospital, Japan"},{"name":"Department of Emergency Medicine, Ohta-Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Shinbo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ohta-Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Hoflich C, Sabat R, Rosseau S, et al. Naturally occurring anti-IFN-\u03b3 autoantibody and severe infections with <i>Mycobacterium chelonae<\/i> and <i>Burkholderia cocovenenans<\/i>. Blood 103: 673-675, 2004.","DOI":"10.1182\/blood-2003-04-1065"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Doffinger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis 38: 673-675, 2004.","DOI":"10.1086\/380453"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med 367: 725-734, 2012.","DOI":"10.1056\/NEJMoa1111160"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tanaka Y, Hori T, Ito K, Fujita T, Ishikawa T, Uchiyama T. Desseminated <i>Mycobacterium avium<\/i> complex infection in a patient with autoantibody to interferon-\u03b3. Intern Med 46: 1005-1009, 2007.","DOI":"10.2169\/internalmedicine.46.6452"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Koya T, Tsubata C, Kagamu H, et al. Anti-interferon-\u03b3 autoantibody in a patient with disseminated <i>mycobacterium avium complex<\/i>. J Infect Chemother 15: 118-122, 2009.","DOI":"10.1007\/s10156-008-0662-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ishii T, Tamura A, Matsui H, et al. Disseminated <i>Mycobacterium avium<\/i> complex infection in a patient carrying autoantibody to interferon-\u03b3. J Infect Chemother 19: 1152-1157, 2013.","DOI":"10.1007\/s10156-013-0572-2"},{"key":"7","unstructured":"7. Toida K, Watanabe K, Kugiyama K, et al. A case of disseminated nontuberculous mycobacterial infection with anti-interferon-\u03b3 antibody. Nihon Kokyuki Gakkai Shi (Annals of The Japanese Respiratory Society) 2: 836-840, 2013 (in Japanese, Abstract in English)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hase I, Morimoto K, Sakagami T, Kazumi Y, Ishii Y, van Ingen J. Disseminated <i>Mycobacterium gordonae<\/i> and <i>Mycobacterium mantenii<\/i> infection with elevated anti-IFN-\u03b3 neutralizing autoantibodies. J Infect Chemother 21: 468-472, 2015.","DOI":"10.1016\/j.jiac.2015.02.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nishimura T, Fujita-Suzuki Y, Yonemaru M, et al. Recurrence of disseminated <i>Mycobacterium avium<\/i> complex disease in a patient with anti-gammma interferon autoantibodies by reinfection. J Clin Microbiol 53: 1436-1438, 2015.","DOI":"10.1128\/JCM.03339-14"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Chi CY, Chu CC, Liu JP, et al. Anti-IFN-\u03b3 autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood 121: 1357-1366, 2013.","DOI":"10.1182\/blood-2012-08-452482"},{"key":"11","unstructured":"11. DeLeon TT, Chung HH, Opal SM, et al. <i>Mycobacterium avium<\/i> complex empyema in a patient with interferon gamma autoantibodies. Hawaii J Med Public Health 73: 15-17, 2014."},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Browne SK, Zaman R, Sampaio EP, et al. Anti-CD20 (rituximab) therapy for anti-IFN-\u03b3 autoantibody-associated nontuberculous mycobacterial infection. Blood 119: 3933-3939, 2012.","DOI":"10.1182\/blood-2011-12-395707"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Kampitak T, Suwanpimolkul G, Browne S, Suankratay C. Anti-interferon-\u03b3 autoantibody and opportunistic infections: case series and review of the literature. Infection 39: 65-71, 2011.","DOI":"10.1007\/s15010-010-0067-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kampmann B, Hemingway C, Stephens A. Acquired predisposition to mycobacterial disease due to autoantibody to IFN-gamma. J Clin Invest 115: 2480-2488, 2005.","DOI":"10.1172\/JCI19316"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kenjiro S, Takuro S, Yoshinari T, et al. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients. J Infect Chemother 20: 52-56, 2014.","DOI":"10.1016\/j.jiac.2013.08.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Altare F, Jouanguy E, Lamhamedi S, D\u00f6ffinger R, Fischer A, Casanova JL. Mendelian susceptibility to mycobacterial infection in man. Curr Opin Immunol 10: 413-417, 1998.","DOI":"10.1016\/S0952-7915(98)80114-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dupuis S, Doffinger R, Picard C, et al. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 178: 129-137, 2000.","DOI":"10.1034\/j.1600-065X.2000.17810.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Doffinger R, Altare F, Casanova JL. Genetic heterogeneity of Mendelian susceptibility to mycobacterial infection. Microbes Infect 2: 1553-1557, 2000.","DOI":"10.1016\/S1286-4579(00)01311-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Casanova JL. Mendelian susceptibility to mycobacterial infection in man. Swiss Med Wkly 131: 445-454, 2001.","DOI":"10.4414\/smw.2001.09763"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lee PP. Disseminated Bacillus Calmette-Guerin and susceptibility to mycobacterial infections-implications on Bacillus Calmette-Guerin vaccinations. Ann Acad Med Singapore 44: 297-301, 2015.","DOI":"10.47102\/annals-acadmedsg.V44N8p297"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Strickler A, Perez A, Risco M, Gallo S. Bacillus Calmette-Guerin (BCG) disease and interleukin 12 receptor \u03b21 deficiency: clinical experience of two familial and one sporadic case. Rev Chiela Infectol 31: 444-451, 2014 (in Spanish, Abstract in English).","DOI":"10.4067\/S0716-10182014000400010"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Van de Vosse E, Ottenhoff TH, de Paus RA. <i>Mycobacterium bovis<\/i> BCG-itis and cervical lymphadenitis due to Salmonella enteritidis in a patient with complete interleukin-12\/-23 receptor beta1 deficiency. Infection 38: 128-130, 2010.","DOI":"10.1007\/s15010-009-9222-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lee Wl, Huang JL, Wu TS, et al. Patients with inhibitory and neutralizing auto-antibodies to interferon-\u03b3 resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking bacille Calmette-Guerin (BCG)-induced diseases. Immunobiology 218: 762-771, 2013.","DOI":"10.1016\/j.imbio.2012.08.281"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416, 2007.","DOI":"10.1164\/rccm.200604-571ST"},{"key":"25","unstructured":"25. Committee on Management of Non-Tuberculous Acid-Fast Bacterial Infection Japanese Society of Tuberculosis; Infection and Tuberculosis Section of Japanese Society of Respiratory Diseases. Opinions on chemotherapy of non-tuberculous acid-fast bacterial infection of the lung. Kekkaku (Tuberculosis) 87: 83-86, 2012 (in Japanese, Abstract in English)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Bhikoo R, Bevan R, Sims J. Multifocal choroiditis with panuveitis in a patient with disseminated <i>Mycobacterium avium<\/i> complex. Retin Cases Brief Rep 7: 155-157, 2013.","DOI":"10.1097\/ICB.0b013e3182790ef9"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Zamir E, Hudson H, Ober RR, et al. Massive mycobacterial choroiditis during highly active antiretroviral therapy: another immune-recovery uveitis? Ophthalmology 109: 2144-2148, 2002.","DOI":"10.1016\/S0161-6420(01)01048-X"},{"key":"28","unstructured":"28. Cohen JI, Saragas SJ. Endophthalmitis due to <i>Mycobacterium avium<\/i> in a patient with AIDS. Ann Ophthalmol 22: 47-51, 1990."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kheir WJ, Sheheitli H, Abdul Fattah M, Hamam RN. Nontuberculous mycobacterial ocular infections: a systematic review of the literature. Biomed Res Int 2015 (in press).","DOI":"10.1155\/2015\/164989"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Chong C, Sinclair J, Voss L, et al. Ophthalmic manifestation of disseminated cutaneous <i>Mycobacterium avium-intracellulare<\/i> complex in a child with a presumed primary IL-12 receptor defect. Ocul Immunol Inflamm 23: 106-109, 2015.","DOI":"10.3109\/09273948.2014.920510"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/20\/55_55.6896\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T13:06:39Z","timestamp":1692536799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/20\/55_55.6896\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":30,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6896","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}